| Active ingredient (INN) | Repaglinide |
|---|---|
| Brand names |
|---|
| Act Repaglinide |
| ATC level 5 | A10BX02 |
|---|
| ATC level 4 | A10BX |
|---|
| Therapeutic category | Auto-created by Health Canada — Drug Shortages Database scraper |
|---|
| Controlled substance | No |
|---|
| Marketing-authorisation holders | MACLEODS PHARMACEUTICALS LIMITED, Teva Pharma B.V., KRKA, d.d., Novo mesto, Accord Healthcare S.L.U. +3 more |
|---|
| Registrations on file | 9 |
|---|
| Patient information leaflet (PIL) | Not on file |
|---|
| Summary of product characteristics (SPC) | Not on file |
|---|
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| Repaglinide | .5mg/1 | tablet | 🇺🇸 US | MACLEODS PHARMACEUTICALS LIMITED | Active |
| Repaglinide | 1mg/1 | tablet | 🇺🇸 US | MACLEODS PHARMACEUTICALS LIMITED | Active |
| Repaglinide | 2mg/1 | tablet | 🇺🇸 US | MACLEODS PHARMACEUTICALS LIMITED | Active |
| Repaglinide Teva | — | — | 🌐 EU | Teva Pharma B.V. | Active |
| Repaglinide Krka | — | — | 🌐 EU | KRKA, d.d., Novo mesto | Active |
| Repaglinide Accord | — | — | 🌐 EU | Accord Healthcare S.L.U. | Active |
| Repaglinide Sun | — | — | 🌐 EU | Sun Pharmaceutical Industries B.V. | Application withdrawn |
| Jamp Repaglinide | — | tablet | 🇨🇦 CA | JAMP PHARMA CORPORATION | Active |
| Sandoz Repaglinide | — | tablet | 🇨🇦 CA | SANDOZ CANADA INCORPORATED | Active |